CN1748784A - Process for producing ampeptide element - Google Patents
Process for producing ampeptide element Download PDFInfo
- Publication number
- CN1748784A CN1748784A CNA2005100456138A CN200510045613A CN1748784A CN 1748784 A CN1748784 A CN 1748784A CN A2005100456138 A CNA2005100456138 A CN A2005100456138A CN 200510045613 A CN200510045613 A CN 200510045613A CN 1748784 A CN1748784 A CN 1748784A
- Authority
- CN
- China
- Prior art keywords
- adds
- eluent
- mentioned
- effluent
- drying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The technological process of producing amino peptide essence includes sorting hog nail, washing, hydrolysis, drying, crushing, superfine grinding, lixiviation to separate and resin exchange to purify, and has high bioavailability.
Description
Technical field:
What the present invention relates to is pharmaceutical technology, particularly the ampeptide elemente production method.
The prior art situation:
Ampeptide elemente is the treatment idiopathic thrombocytopenic purpura of the development eighties, leukopenia, and aplastic anemia also can be used for psoriatic biochemical drug.
Domestic existing process for producing ampeptide element is to adopt high-temperature hydrolysis process fully at present, and the hydrolyzed product convection drying is pulverized, and is processed into finished product.This process simple coarse fails effective ingredient in the raw material is carried out purification, causes the finished product active constituent content low, and bioavailability is low, and total nitrogen is 13%, and amino nitrogen accounts for 2% of total nitrogen.
Summary of the invention
The objective of the invention is to improve, the process for producing ampeptide element that a kind of method is easy, improve the active constituent content of bioavailability, raising product is provided at the deficiency of prior art ampeptide elemente production technology.
The inventive method is in former technology: Unguis Sus domestica is selected cleaning---on the basis of hydrolysis---drying---pulverizing, adopts micronizing, lixiviate separation, resins exchange technical method to reach purification, improves bioavailability.
Process of the present invention is:
(1), Unguis Sus domestica is selected, is cleaned;
(2), hydrolysis;
(3), drying;
(4), pulverize;
(5), micronizing: above-mentioned medicated powder is pressed 1: 2-3 adds purified water, stirs, and last colloid barreling mill gets the superfine powder suspension;
(6), lixiviate separates:
A, with above-mentioned mixed liquor in 1: the ratio of 7-8 adds 5% sodium hydroxide, stirs at interval lixiviate 20-24 hour; Filter then;
B, residue is added 5% sodium hydroxide again carry out lixiviate, filtration;
C, merging filtrate precipitate;
D, drying; With above-mentioned precipitate dried under reduced pressure, must make with extra care the ampeptide elemente crude product;
(7), resins exchange:
A, with above-mentioned crude product water dissolution, transfer pH value 2.5, adsorb with styrene type cation exchange resin, control flow velocity 500~1000ML/h treats that effluent adds when the ninhydrin solution heated and boiled shows bluish violet to receive effluent, till effluent PH5-6;
B, again with the ammonia eluting, receive eluent, to eluent PH14, and eluent adds the ninhydrin solution heated and boiled and do not show bluish violet, and eluent adds 10% sodium hydroxide and be alkaline solution, adds 2 5% copper-baths tests and do not show till the purples;
C, merging effluent and eluent;
(8), concentrate: with above-mentioned amalgamation liquid in 90 ℃ of left and right sides evaporation and concentration, to the thick paste shape;
(9), drying: must make with extra care ampeptide elemente.
Though technology of the present invention has increased the processing technique step on the basis of former technology, the product effective ingredient polypeptide, the amino acid content that make through this technology improve, and bioavailability improves, and product quality has than much progress than former handicraft product.
Survey report is as follows:
Project | 20040401 | 20040402 | 20040403 |
Character | Faint yellow | Faint yellow | Faint yellow |
Differentiate | Be positive reaction | Be positive reaction | Be positive reaction |
Microbial limit | Up to specification | Up to specification | Up to specification |
Total nitrogen | 26.72% | 26.52% | 26.94% |
Amino nitrogen | 2.58% | 2.53% | 2.50% |
Embodiment:
(1), Unguis Sus domestica is selected, is cleaned;
(2), hydrolysis;
(3), drying;
(4), pulverize;
(5), micronizing: above-mentioned medicated powder was added purified water by 1: 2, stir, last colloid barreling mill gets the superfine powder suspension;
(6), lixiviate separates:
A, above-mentioned mixed liquor is added 5% sodium hydroxide in 1: 8 ratio, stirred lixiviate 24 hours every one hour; Filter then;
B, residue is added 5% sodium hydroxide again carry out lixiviate, filtration;
C, merging filtrate precipitate;
D, drying with above-mentioned precipitate dried under reduced pressure, must be made with extra care the ampeptide elemente crude product;
(7), resins exchange:
A, with above-mentioned crude product water dissolution, transfer pH value 2.5, adsorb with styrene type cation exchange resin, control flow velocity 500~1000ML/h treats that effluent adds when the ninhydrin solution heated and boiled shows bluish violet to receive effluent, till effluent PH5-6;
B, again with the ammonia eluting, receive eluent, to eluent PH14, and eluent adds the ninhydrin solution heated and boiled and do not show bluish violet, and eluent adds 10% sodium hydroxide and be alkaline solution, adds 2 5% copper-baths tests and do not show till the purples;
C, merging effluent and eluent;
(8), concentrate: with above-mentioned amalgamation liquid in 90 ℃ of left and right sides evaporation and concentration, to the thick paste shape;
(9), drying:, must make with extra care ampeptide elemente with drying under reduced pressure case drying.
Claims (1)
1, process for producing ampeptide element is characterized in that:
(1), Unguis Sus domestica is selected, is cleaned;
(2), hydrolysis;
(3), drying;
(4), pulverize;
(5), micronizing: above-mentioned medicated powder is pressed 1: 2-3 adds purified water, stirs, and last colloid barreling mill gets the superfine powder suspension;
(6), lixiviate separates:
A, with above-mentioned mixed liquor in 1: the ratio of 7-8 adds 5% sodium hydroxide, stirs at interval lixiviate 20-24 hour; Filter then;
B, residue is added 5% sodium hydroxide again carry out lixiviate, filtration;
C, merging filtrate precipitate;
D, drying; With above-mentioned precipitate dried under reduced pressure, must make with extra care the ampeptide elemente crude product;
(7), resins exchange:
A, with above-mentioned crude product water dissolution, transfer pH value 2.5, adsorb with styrene type cation exchange resin, control flow velocity 500~1000ML/h treats that effluent adds when the ninhydrin solution heated and boiled shows bluish violet to receive effluent, till effluent PH5-6;
B, again with the ammonia eluting, receive eluent, to eluent PH14, and eluent adds the ninhydrin solution heated and boiled and do not show bluish violet, and eluent adds 10% sodium hydroxide and be alkaline solution, adds 2 5% copper-baths tests and do not show till the purples;
C, merging effluent and eluent;
(8), concentrate: with above-mentioned amalgamation liquid in 90 ℃ of left and right sides evaporation and concentration, to the thick paste shape;
(9), drying: must make with extra care ampeptide elemente.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100456138A CN1294986C (en) | 2005-01-06 | 2005-01-06 | Process for producing ampeptide element |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100456138A CN1294986C (en) | 2005-01-06 | 2005-01-06 | Process for producing ampeptide element |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1748784A true CN1748784A (en) | 2006-03-22 |
CN1294986C CN1294986C (en) | 2007-01-17 |
Family
ID=36604561
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100456138A Expired - Fee Related CN1294986C (en) | 2005-01-06 | 2005-01-06 | Process for producing ampeptide element |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1294986C (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101773660A (en) * | 2010-03-17 | 2010-07-14 | 张大宇 | Medicament containing anubi-polypeotide |
CN101979656A (en) * | 2010-11-11 | 2011-02-23 | 武汉远城科技发展有限公司 | Method for extracting hoof peptide |
CN103549249A (en) * | 2013-10-11 | 2014-02-05 | 吕明 | Purification technology for propolis |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1063874A (en) * | 1991-02-07 | 1992-08-26 | 杭州肉类联合加工厂 | From poultry hair or coffin, extract the method for soluble keratin |
CN1129440C (en) * | 2000-05-11 | 2003-12-03 | 齐鲁制药厂 | Piles treating medicine and its prepn. |
CN1204118C (en) * | 2001-09-04 | 2005-06-01 | 叶小利 | Comprehensive cystine mother liquor utilizing process of producing single amino acid and eliminating pollution |
CN1208312C (en) * | 2002-03-13 | 2005-06-29 | 何文义 | New process for preparing compound amino acid by using animal hoof and foot |
-
2005
- 2005-01-06 CN CNB2005100456138A patent/CN1294986C/en not_active Expired - Fee Related
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101773660A (en) * | 2010-03-17 | 2010-07-14 | 张大宇 | Medicament containing anubi-polypeotide |
CN101773660B (en) * | 2010-03-17 | 2011-08-31 | 李国� | Medicament containing anubi-polypeotide |
CN101979656A (en) * | 2010-11-11 | 2011-02-23 | 武汉远城科技发展有限公司 | Method for extracting hoof peptide |
CN101979656B (en) * | 2010-11-11 | 2012-06-06 | 武汉远城科技发展有限公司 | Method for extracting hoof peptide |
CN103549249A (en) * | 2013-10-11 | 2014-02-05 | 吕明 | Purification technology for propolis |
Also Published As
Publication number | Publication date |
---|---|
CN1294986C (en) | 2007-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112409132B (en) | Method for separating inositol and by-products | |
CN101798273B (en) | Valine purification method | |
Boonmee et al. | Improved lactic acid production by in situ removal of lactic acid during fermentation and a proposed scheme for its recovery | |
CN106046248B (en) | Cationic flocculant and preparation method thereof | |
CN101525306A (en) | Method for extracting and separating natural taurine from octopus leftovers | |
CN1294986C (en) | Process for producing ampeptide element | |
CN105348122A (en) | Method for purifying L-alanine final mother liquor | |
CN1117752C (en) | Method for purifying and crystallizing vitamin B2 | |
CN1035000C (en) | Method of extracting citric acid from citric acid fermentation liquor | |
CN1156464C (en) | Refining process of electron level oxydiphenyl diformic anhydride | |
CN111499537B (en) | Refining and purifying method of plant-derived ceramide extract | |
CN1775744A (en) | Leucine extracting method | |
CN1056190C (en) | Citric acid extracting process | |
CN109206486A (en) | A kind of impurity and preparation method thereof of sulfuric acid Polymyxin B sulfate | |
CN111606856B (en) | Method for separating carnosine and histidine | |
CN1229332C (en) | Extraction process of 15N-L-phenylalanine | |
CN1217901C (en) | High-yield manna sugar preparation process | |
CN1282639C (en) | Continuous ion exchage extracting process for L-phenylalanine | |
CN109180512B (en) | Method for removing glutamic acid from gamma-aminobutyric acid fermentation liquor | |
CN85109246A (en) | The method for preparing crystalline L-glutamic acid and salt thereof | |
CN102382150B (en) | Preparation method of high-purity mixed sodium deoxyribonucleotide | |
CN106591406B (en) | Method for preparing bone gelatin by using ultrasonic-assisted enzyme method | |
CN104876856A (en) | Method for preparing (R)-(+)-3-piperidinamine dihydrochloride by using resolution method | |
CN116478055A (en) | Chiral refining method of aspartic acid | |
CN117417278A (en) | Production method for producing ammonia three powder by mother liquor proportioning |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |